{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-265516","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2021-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.505048+00:00","generated_at":"2026-06-29T05:55:26.506467+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tenet Healthcare CEO transition: Rittenmeyer to Executive Chairman, Sutaria becomes CEO Sept 1, 2021","bullets":["Ronald Rittenmeyer transitions from CEO to Executive Chairman through 2022, then advisor through 2024; base salary $1.5M then $750K, retention bonus $5M.","Saumya Sutaria promoted to CEO effective Sept 1, 2021; base salary $1.2M, target bonus 125% of salary, equity award $8M in RSUs.","Sutaria's employment agreement initial term through Dec 31, 2025, with automatic one-year renewals; severance provisions detailed.","Rittenmeyer receives $5M retention bonus payable Dec 31, 2024 if employed through Term; accelerated vesting on qualifying termination.","Both executives subject to perpetual confidentiality, non-disparagement, and post-employment non-compete/non-solicit covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-265516","json":"https://secwatch.observer/filing/0001193125-21-265516.json","markdown":"https://secwatch.observer/filing/0001193125-21-265516.md","text":"https://secwatch.observer/filing/0001193125-21-265516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/d268536d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T05:55:26.506467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49561ba917","claim":"Ronald A. Rittenmeyer changed role as Executive Chairman at TENET HEALTHCARE CORP.","evidence_excerpt":"Ronald A. Rittenmeyer will transition from Chief Executive Officer of the Company and continue as the Executive Chairman of the Company and the Company’s board of directors (the “ Board ”) through 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"88ae686566","claim":"Saumya Sutaria, M.D. changed role as Chief Executive Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Saumya Sutaria, M.D., will be promoted from President and Chief Operating Officer of the Company to Chief Executive Officer of the Company, in each case effective as of September 1, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}